Your browser doesn't support javascript.
loading
The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity.
Mellado-Gil, Jose M; Fuente-Martín, Esther; Lorenzo, Petra I; Cobo-Vuilleumier, Nadia; López-Noriega, Livia; Martín-Montalvo, Alejandro; Gómez, Irene de Gracia Herrera; Ceballos-Chávez, Maria; Gómez-Jaramillo, Laura; Campos-Caro, Antonio; Romero-Zerbo, Silvana Y; Rodríguez-Comas, Júlia; Servitja, Joan-Marc; Rojo-Martinez, Gemma; Hmadcha, Abdelkrim; Soria, Bernat; Bugliani, Marco; Marchetti, Piero; Bérmudez-Silva, Francisco J; Reyes, Jose C; Aguilar-Diosdado, Manuel; Gauthier, Benoit R.
Affiliation
  • Mellado-Gil JM; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Fuente-Martín E; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Lorenzo PI; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Cobo-Vuilleumier N; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • López-Noriega L; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Martín-Montalvo A; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Gómez IGH; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Ceballos-Chávez M; Department of Genome Biology, Andalusian Center of Molecular Biology and Regenerative Medicine (CABIMER) JA-CSIC-UPO-US, Seville, Spain.
  • Gómez-Jaramillo L; Research Unit, University Hospital "Puerta del Mar", Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), Cádiz, Spain.
  • Campos-Caro A; Research Unit, University Hospital "Puerta del Mar", Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), Cádiz, Spain.
  • Romero-Zerbo SY; Unidad de Gestión Clínica Intercentros de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain.
  • Rodríguez-Comas J; Diabetes & Obesity Research Laboratory, Biomedical Research Institute August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Servitja JM; Diabetes & Obesity Research Laboratory, Biomedical Research Institute August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Rojo-Martinez G; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
  • Hmadcha A; Unidad de Gestión Clínica Intercentros de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain.
  • Soria B; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
  • Bugliani M; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Marchetti P; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
  • Bérmudez-Silva FJ; Department of Cell Regeneration and Advanced Therapies, Andalusian Center of Molecular Biology and Regenerative Medicine-CABIMER, Junta de Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
  • Reyes JC; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
  • Aguilar-Diosdado M; Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.
  • Gauthier BR; Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.
Cell Death Dis ; 9(3): 279, 2018 02 15.
Article in En | MEDLINE | ID: mdl-29449530
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: High Mobility Group Proteins / Polymorphism, Single Nucleotide / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Insulin-Secreting Cells Type of study: Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cell Death Dis Year: 2018 Document type: Article Affiliation country: España Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: High Mobility Group Proteins / Polymorphism, Single Nucleotide / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Insulin-Secreting Cells Type of study: Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cell Death Dis Year: 2018 Document type: Article Affiliation country: España Country of publication: Reino Unido